(Q40321932)

English

The new era in cancer research

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

19 September 2017

The new era in cancer research (English)

1 reference

stated in

Europe PubMed Central

19 September 2017

1

Harold Varmus

1 reference

stated in

Europe PubMed Central

PubMed ID

16728627

retrieved

19 September 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

stated in

Europe PubMed Central

19 September 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

Science

1 reference

stated in

Europe PubMed Central

19 September 2017

312

1 reference

stated in

Europe PubMed Central

19 September 2017

1162-1165

1 reference

stated in

Europe PubMed Central

19 September 2017

5777

1 reference

stated in

Europe PubMed Central

19 September 2017

Stem cells, cancer, and cancer stem cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

The Hallmarks of Cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Angiogenesis as a therapeutic target

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Hereditary cancer predisposition syndromes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Cancer statistics, 2005

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Use of gene expression profiling to direct in vivo molecular imaging of lung cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Molecular themes in oncogenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Cancer. Addiction to oncogenes--the Achilles heal of cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

BRAF mutation predicts sensitivity to MEK inhibition

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Cysteine cathepsins in human cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Reversibility of oncogene-induced cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

GENE SEQUENCING: The Race for the $1000 Genome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

The biology of human lymphoid malignancies revealed by gene expression profiling.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Prospective identification of tumorigenic breast cancer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Therapeutic implications of cancer stem cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Epigenetic therapy of cancer: past, present and future

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

CTLA-4: new insights into its biological function and use in tumor immunotherapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Tumor-stroma interactions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1126758

Identifiers

DOI

10.1126/SCIENCE.1126758

1 reference

stated in

Europe PubMed Central

19 September 2017

0 references

1 reference

Europe PubMed Central

PubMed ID

16728627

retrieved

19 September 2017

ResearchGate publication ID

7053362

0 references

(Q40321932)

The new era in cancer research

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)